Press release
May 7, 2026
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.
Catalyst Pharmaceuticals, Inc. (CPRX)
We couldn't retrieve the full text for this release. Read it on the company's site.